astragaloside a has been researched along with Infarction, Middle Cerebral Artery in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 6 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, T; Gao, X; Li, S; Li, Z; Wang, Z; Zou, Y | 1 |
| He, Y; Huang, B; Huang, J; Meng, Y; Shen, F; Wang, L | 1 |
| Ding, Z; He, Y; Lin, B; Wan, H; Wei, X; Yang, J; Yin, J; Zhou, H | 1 |
| Chen, J; Chen, L; Han, Y; Hu, X; Miao, H; Ou, Z; Wang, Y; Yao, J | 1 |
| Duan, CQ; Liang, C; Ni, GX; Wang, J; Wang, P; Wang, YL | 1 |
| Chu, L; Fang, Y; Gan, H; Hu, X; Jin, H; Li, L; Yang, Y; Zhang, J | 1 |
| Jiao, S; Li, Y; Liu, B; Yang, Y; Zhang, J; Zhang, X; Zhao, Y | 1 |
| Deng, CQ; Tang, B; Tang, WJ; Tang, YH | 1 |
| Gong, HL; Li, WP; Li, WZ; Wu, GC; Yin, YY; Zhu, FF | 1 |
| Chen, J; Ding, D; Fu, JH; Hong, Z; Luo, Y; Qin, Z; Zhang, WD; Zhang, X | 1 |
10 other study(ies) available for astragaloside a and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Astragaloside IV ameliorates peripheral immunosuppression induced by cerebral ischemia through inhibiting HPA axis.
Topics: Animals; Humans; Hypothalamo-Hypophyseal System; Immunosuppression Therapy; Infarction, Middle Cerebral Artery; Mice; Pituitary-Adrenal System; Saponins; Triterpenes | 2022 |
Antihypertension effect of astragaloside IV during cerebral ischemia reperfusion in rats.
Topics: Animals; Brain Ischemia; Disease Models, Animal; Infarction, Middle Cerebral Artery; Rats; Rats, Sprague-Dawley; Reperfusion; Reperfusion Injury; Saponins; Triterpenes | 2023 |
Integrated transcriptomics, proteomics and metabolomics to identify biomarkers of astragaloside IV against cerebral ischemic injury in rats.
Topics: Animals; Biomarkers; Brain Injuries; Brain Ischemia; Drugs, Chinese Herbal; Infarction, Middle Cerebral Artery; Metabolomics; Proteomics; Rats; Rats, Sprague-Dawley; Transcriptome | 2023 |
Astragaloside IV promotes angiogenesis by targeting SIRT7/VEGFA signaling pathway to improve brain injury after cerebral infarction in rats.
Topics: Animals; Brain Injuries; Brain Ischemia; Infarction, Middle Cerebral Artery; Molecular Docking Simulation; Oxygen; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction; Sirtuins | 2023 |
Astragaloside IV improves neurobehavior and promotes hippocampal neurogenesis in MCAO rats though BDNF-TrkB signaling pathway.
Topics: Animals; Brain-Derived Neurotrophic Factor; Hippocampus; Infarction, Middle Cerebral Artery; Male; Neurogenesis; Neuroprotective Agents; Rats, Sprague-Dawley; Receptor, trkB; Saponins; Signal Transduction; Stroke; Triterpenes | 2020 |
Astragaloside IV promotes microglia/macrophages M2 polarization and enhances neurogenesis and angiogenesis through PPARγ pathway after cerebral ischemia/reperfusion injury in rats.
Topics: Animals; Brain Injuries; Cell Polarity; Disease Models, Animal; Infarction, Middle Cerebral Artery; Macrophages; Male; Microglia; Neovascularization, Physiologic; Neurogenesis; PPAR gamma; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Saponins; Triterpenes | 2021 |
Astragaloside IV reduces neuronal apoptosis and parthanatos in ischemic injury by preserving mitochondrial hexokinase-II.
Topics: Animals; Apoptosis Inducing Factor; Astragalus propinquus; Female; Gene Expression Regulation; Glutamic Acid; Hexokinase; Humans; Hypoxia-Ischemia, Brain; Infarction, Middle Cerebral Artery; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Neurons; Neuroprotective Agents; Oxygen Consumption; Parthanatos; Primary Cell Culture; Protein Binding; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Saponins; Triterpenes | 2019 |
[Astragaloside IV attenuates cerebral ischemia and reperfusion injury and reduces activation of NLRP3 inflammasome and NF-κB phosphorylation in rats following a transient middle cerebral artery occlusion].
Topics: Animals; Brain Ischemia; Infarction, Middle Cerebral Artery; Inflammasomes; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Phosphorylation; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Saponins; Triterpenes | 2019 |
Protective effect of astragaloside on focal cerebral ischemia/reperfusion injury in rats.
Topics: Animals; Brain; Brain Ischemia; Cerebral Infarction; Drugs, Chinese Herbal; Infarction, Middle Cerebral Artery; L-Lactate Dehydrogenase; Lactates; Male; Malondialdehyde; Nerve Growth Factor; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Receptor, trkA; Reperfusion Injury; Reverse Transcriptase Polymerase Chain Reaction; Saponins; Superoxide Dismutase; Time Factors; Triterpenes; Water | 2010 |
Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia.
Topics: Animals; Brain Chemistry; Brain Ischemia; Cardiotonic Agents; Catalase; Cerebral Infarction; Disease Models, Animal; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Glutathione Peroxidase; Infarction, Middle Cerebral Artery; Lipid Peroxidation; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Reperfusion Injury; Saponins; Superoxide Dismutase; Triterpenes | 2004 |